Practo partners with Thyrocare to make these tests available in Mumbai, to begin with
ICMR & Government of India certified labs
Practo, India’s leading digital healthcare platform, today announced that Covid-19 testing is now available for booking on its platform. The company has partnered with Thyrocare to conduct Covid-19 detection tests, which has been authorised by the Government of India and The Indian Council of Medical Research (ICMR). Starting today, the test is available for Mumbai residents, and will soon be expanded to the rest of the country.
A valid doctor’s prescription, duly filled Test Requisition Form signed by the physician, and a photo ID card has to be presented at the time of testing. The test will be available at Rs 4500/- and can be booked at https://www.practo.com/covid-test and https://covid.thyrocare.com/.
Certified phlebotomists from I2H will collect the samples from the patients’ homes directly. They will be taking all necessary precautions mentioned in the ICMR guidelines while taking the swabs. The Swab that is taken during the test will be collected in a viral transport medium (VTM) and will be transported in a cold chain to the Thyrocare laboratory which has been selected for COVID-19 testing. The report will be made available to the patients on the Practo website within 24-48 hours of the sample collection.
Dr Alexander Kuruvilla, Chief Health Strategy Officer, Practo, said, “Widespread testing is critical to track the scale and prevent the transmission of Covid-19. To ensure that anyone who experiences the symptoms of the infection can get tested, the government is constantly working on expanding the list of labs and centers. We’ve partnered with Thyrocare to ensure that access to these tests is not an issue. We will continue to work closely with the authorities to identify more such areas where Practo can solve for accessibility – be it for doctor consultations, testing or medicine delivery. We stand firmly committed to our vision of making quality healthcare accessible to all Indians, esp. in difficult times such as these.”
Dr. A. Velumani, Chairman and Managing Director of Thyrocare Technologies Ltd said, “Thyrocare wishes to keep it affordable, reach to the bottom of the pyramid and produce significant impact in the nation’s fight against COVID.”
For millions of people, Practo is their trusted home, where they know they will find the healing touch. Practo is the place that connects them to everything that they need to take good care of themselves and their families, assessing health issues, finding the right doctor, managing records securely, and finding new ways to live a longer, healthier life. Healthcare providers and other healthcare partners use Practo because it is the trusted home for health for millions of people. Practo provides a definitive platform for them to build their presence, to grow their practice or business, and to engage their patients in a way that was never possible before.
As technology becomes an integral part of healthcare, Practo has also become an essential enabler in helping doctors understand the nuances of managing and securely storing all health data. Practo encrypts all data with 256-bit encryption (many banks use just 128-bit), uses HIPAA compliant data centers, and is one of the few healthcare companies to be ISO 27001 certified. Today, Practo is present in 21 countries, helps 18 crore+ patients a year, and connects patients with 1 lakh+ verified healthcare providers.
Thyrocare is a BSE and NSE listed entity with presence in 3000 locations including 10 countries and is focused on Preventive care in Lifestyle disorders.
With a belief that ‘Quality’ is the heart of any intelligent management, Thyrocare became one of the first Indian diagnostic laboratories to obtain internationally renowned quality accreditation like ISO 9001-2000 rating as early as 2001, which is now escalated to ISO 9001:2008 and CAP (College of American Pathologists) certification in 2007